CYCLERION THERAPEUTICS, INC. Transfer to Investments
CYCLERION THERAPEUTICS, INC. (CYCN) reported Transfer to Investments of $5.35 million for the 12-month period ending 2023-12-31, per its 10-K/A filed 2025-11-12.
Financial Statements › Cash Flow
us-gaap:TransferToInvestments · last filed 2025-11-12
- CYCLERION THERAPEUTICS, INC. transfer to investments for the quarter ending 2023-12-31 was $0.00.
- CYCLERION THERAPEUTICS, INC. transfer to investments for fiscal 2023 was $5.35M.
| Period end | Transfer to Investments 3 month | Transfer to Investments 9 month | Transfer to Investments 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-11-12 | $5.35M 10-K/A · filed 2025-11-12 | |
| 2023-09-30 | $5.35M 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |